Dayton Judd
CEO
Replay available
FitLife Brands (NASDAQ:FTLF) reported Q3 2026 results on this call. Replay available.

On 6ix: 6ix.com/event/fitlife-brands-inc-ftlf-q3-2026-earnings-call
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:00 Please note, this conference is being recorded. I will now turn the conference over to your host, Dayton Judd. You may begin.
0:09 Good afternoon. I'd like to welcome everyone to FitLife's third quarter 2026 earnings call. We appreciate you taking the time to join us this afternoon. Joining me on the call is FitLife's president, Ryan Hansen, and FitLife's CFO, Jakob York. For the third quarter of 2026, total revenue was $25.6 million, an increase of 9% from the third quarter of 2025. Growth came from a full quarter of Irwin, partially offset by a year-over-year revenue decline for Legacy FitLife. Online revenue was $11.8 million, an increase of 15% year-over-year, and represented 46% of total revenue.
0:59 Gross margin was 37.7% up from 37.2% a year ago. Excluding the $0.4 million of inventory step-up amortization in the prior year quarter, the gross margin during the third quarter last year was 38.9%. Gross margin improved sequentially from 37.0% in the second quarter. Contribution, which we define as gross profit less advertising and marketing expense, grew 10% to $8.1 million, or 31.5% of revenue. Net income was $1.6 million, up 71% from $0.9 million a year ago. Diluted earnings per share was $0.16 compared to $0.09 last year, and basic earnings per share was $0.17 compared to $0.10 last year.
1:55 Adjusted EBITDA was $3.3 million compared to $3.8 million a year ago. For the trailing 12 months, the company generated $103.4 million of revenue and $13.7 million of adjusted EBITDA. Although some brands and channels continue to be challenged, others are growing. Sequentially, for each of the past four quarters, revenue for the combined business has been relatively stable between 25.3 and 26.5 million, and adjusted EBITDA has also been consistently between 3.3 and 3.7 million. During the third quarter, we completed a restructuring initiative to improve efficiency and lower our cost structure.
2:41 We recorded $0.3 million of restructuring expense, primarily severance, and we expect the initiative to reduce annual operating expense by approximately $1.2 million with savings beginning in the fourth quarter of 2026. Turning to brand level performance, I'll start with Legacy FitLife, which includes MRC and MusclePharm. Legacy FitLife revenue was $12.6 million, and it has been stable throughout the year, growing 1.5% sequentially in the third quarter of 2026 compared to the second quarter of 2026. Year over year, wholesale revenue for Legacy FitLife was down 34%, primarily due to reduced sales to certain retail partners, mainly GNC.
3:29 However, wholesale revenue for Legacy FitLife has increased sequentially from Q1 to Q2 and from Q2 to Q3, largely offsetting the declines in online revenue driven by MRC. Online revenue for Legacy FitLife was $8.2 million, or 65% of total revenue. Gross margin for Legacy FitLife was 41.6%, up from 39.3% a year ago, and similar to the second quarter's 41.7% gross margin. Contribution from Legacy FitLife was $4.2 million, or 33.6% of revenue, up from 31.5% during the third quarter of 2025. Sequentially, the legacy FitLife business has been remarkably stable over the last three quarters.
4:21 Total revenue has ranged between $12.4 and $12.6 million, with sequential growth in wholesale revenue largely offsetting the sequential declines in online revenue driven by MRC. Gross margin has ranged between 41.2% and 41.7%, and contribution has ranged between 4.2% and 4.3 million. The MusclePharm brand is doing well, with online revenue during the quarter reaching an all-time high and wholesale revenue reaching its second highest quarter since we have owned the brand. All of this at a significantly higher gross margin. Moving on now to Erwin. Erwin generated $13.0 million of revenue, a 91% increase from the partial period last year.
5:12 Online revenue rose 5% sequentially to $3.6 million and now represents 28% of Irwin's revenue, up from approximately 5% a year ago. Irwin's annual revenue run rate on Amazon exceeded $12 million at the end of the third quarter. Wholesale revenue for Irwin during the quarter was $9.4 million. Gross margin for Irwin during the quarter was 34.0%. and contribution was $3.9 million or 29.6% of revenue. Now I'll provide a few additional high-level comments and then we can open the call for questions. I know some of you like to track subscriber counts, so as of today we have approximately 96,500 active Amazon subscribers, up from 94,000 when we held our previous earnings call in August.
6:04 Our business continues to be challenged by a weak consumer environment and some headwinds such as Amazon algorithms, algorithm changes and softness in the specialty retail and health food channels are outside our control. With that backdrop though, we are building a stronger supply chain and new product pipeline as well as a more efficient cost base. On a consolidated basis, online revenue continues to grow with Irwin and MusclePharm delivering all-time highs during the quarter. And we believe that the cost actions we have taken will favorably impact SG&A and cost of goods sold. These cost actions include the $1.2 million expected savings from the restructuring I previously mentioned, as well as additional non-headcount related savings.
6:52 We ended the quarter with $39.3 million of debt, consisting of $34.5 million on our term loan and $4.8 million on our revolving line of credit. Our net debt increased slightly from $37.0 million at the end of the second quarter to $38.6 million at the end of the third quarter. Given our general trend of reducing indebtedness each quarter, I want to comment on the reasons for the increase. In short, working capital increased $3.5 million sequentially from $9.6 million at the end of the second quarter to $13.1 million at the end of the third quarter. More specifically, inventory increased $1.7 million, receivables increased $1.1 million, and prepaids increased $0.7 million, while payables only increased $0.3 million. A large part of the increase in working capital reflects deliberate decisions we made to lock in commodity pricing through forward purchases of whey protein and fish oil, two commodities facing sharp cost increases due to supply shortages.
8:02 With those payments made, we have locked in fixed price fish oil for the majority of our needs over the next 12 months, and we expect working capital to normalize over time. Over time, we also expect these forward purchases will convert to cash at higher margins than if we had purchased on the spot market. Our weighted average cost of debt is approximately 6.7%, and we intend to continue deploying excess free cash flow toward debt reduction. So that concludes my opening commentary, and we can now go ahead and open it up for questions. Thank you. At this time, we will be conducting a question and answer session.
8:47 If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment, please, while we poll for questions. Once again, please press star one if you have a question or a comment. The first question comes from Ryan Myers with Lake Street. Please proceed.
9:24 Hey, guys. Luke Fingerson on for Ryan Myers. You expect $1.2 million of annual OPEX savings beginning Q4. Should we expect this $300,000 benefit immediately, or does that ramp over a couple quarters?
9:41 Hey, Luke, that'll be the number for Q4. So the actions were actually taken, I'm not going to remember exactly when, but call it mid-August. So it wasn't kind of done at the end of the quarter. We should see kind of the full impact of that. in terms of cash, right? So there's a $0.3 million charge that hits during Q3 in terms of cash out the door. About a third of that was paid out before the end of the third quarter with the remainder being paid in the fourth quarter. So P&L-wise, the full impact, and cash-wise, you'll see some of that trailing into the fourth quarter.
10:20 Got it. And then on MRC... It continues to drive most of the legacy online weakness. Are you seeing any evidence that the rate of decline is moderating?
10:32 Yeah, kind of, but not really. Let me maybe qualify that with some numbers. So we've been seeing kind of strong double-digit declines, about 20% year over year for about somewhere between a little bit more than a year and a half now. The decline started in February of last year, not at the double-digit rates, and then accelerated. In recent, the last three quarters or so, it's still declining, but I would say if you look at the sequential rates, perhaps not as bad. Just to put a finer point on it, in Q1, MRC online revenue was about 5.1. In Q2, it was about 4.9. In Q3, it was about 4.5. The other thing that's happening is Prime Day, right?
11:19 So Dr. Tobias and the other MRC brands are primarily Amazon-based brands. Prime Day was in Q2 this year instead of Q3, which was last year. So some sales that would have been in Q3 were maybe pulled into Q2. So kind of seeing so far sequentially about a half a million decline so far year-to-date. So I guess some moderation, but still declining. That answers your question.
11:49 Yeah, that's helpful. Thank you. Thank you. Okay, your next question is coming from Sean Gowan with Roth Capital. Please proceed.
12:02 Hi, guys. Thanks for taking the questions. Is that a promotion for Ryan?
12:09 Yeah, for Ryan, yeah, Ryan Hansen is the president, so I think we announced that earlier this year. I believe it was in May.
12:16 Oh, okay, so I missed that, but belated congratulations. Following up on the previous questions, can you help us with where on the income statement we would see the benefit of those restructuring savings? Is it all in G&A?
12:33 It's all in G&A. I referenced kind of in the opening that we've done more than that, right? So that 1.2 represents personnel-related savings. There's other things that we have done. We kind of renegotiated our lease or renewed our lease is a better way to say that in Los Angeles where the Irwin office is based at, I would just say, very substantial savings. We didn't need as much space, so the space we have is a lot smaller and the rate is substantially lower, so we'll save like 50% on our occupancy savings. in LA. You kind of work that out. It's in the six figures over the course of a year. There's other initiatives we've done on both the SG&A front and the cost of goods front. But yeah, the only one we kind of quantified, the 1.2 was all personnel related, and that's all flowing through SG&A.
13:24 Okay. Thanks. And then Given that last year had that step-up accounting issue, can you talk about some of the components of gross margin trends? I would have thought you'd be getting a bit more benefit by now from the shift to online.
13:43 Online is still higher margin. The one difference for Erwin, and I think I may have talked about this on a previous call, but if not, I'm happy to kind of address it right now. There's two reasons why Erwin's online margins are not as high as the rest of the business. One is a lot of Erwin's products are lower dollar price. And we include the Amazon referral fee, which is 15%. in our cost of goods, and we also include the Amazon FBA, fulfilled by Amazon shipping charge, in our cost of goods. And when you have a lower dollar price item, the fulfilled by Amazon as a percent of the revenue tends to be higher.
14:36 So that's one reason our margins won't be as high as the rest of the business. If you look at Legacy FitLife, the margins there, you can see they're Quite a bit higher. And that's one of the reasons why. Another challenge that we have with margins is that most of the Irwin products are in glass bottles. And you can't sell glass bottles on Amazon unless each bottle is wrapped in bubble wrap. And then you've got to do labeling or stickering on the outside of the bubble wrap so they can scan it. So right now, our volumes keep going up significantly on Amazon. But for every single item that we ship into Amazon that's in a glass bottle, our three PLs have to open the box, take each bottle out, wrap it in bubble wrap, sticker it, put it in a different box because they're now bigger and they can't fit in the same box, and then ship it into Amazon. We're probably paying more than a dollar a unit right now just on Amazon prep.
15:38 So one way we can address that is we're not going to abandon glass bottles. There's some The value in that, particularly the health food channel, which is where we also sell a lot of product. But for certain high-volume SKUs, we're going to start packing them out in both glass for the brick-and-mortar channel, but then plastic for the Amazon channel. I think our first SKUs with that packout will be probably late this year, early next year. And then we'll start saving kind of a dollar a unit, and we'll start to see kind of higher margins on the online side. Another thing we're doing, and you can go look at our listings and see this, is if one single product is $19.99 on Amazon, we'll create a two-pack version where we're actually packaging two bottles together.
16:34 Instead of charging $40, maybe we'll charge $37 or $36 or something like that, but we pick up quite a bit of savings on the FBA front. So to ship one bottle, Amazon might charge us $3.50. But to ship two bottles packaged together, they charge us $3.80 total or something like that. So that's another way we're making some changes to try and improve our online margins. To be clear, though, online is still more profitable than brick and mortar or than wholesale, I should say. But the margins aren't as attractive as the rest of our business until we kind of make some of these changes.
17:13 Well, if we look down at the legacy business, are you seeing the level of margin improvement that you would expect to get given the shift? Actually, that online business was down, wasn't it?
17:25 Yeah, so online is declining, well, primarily driven by MRC. But you can see kind of gross margins in that business are fairly consistent.
17:36 Yeah, okay. One more question, and I'll jump back in the queue. Sure. Is R1's shift... to online, is there any evidence that that might be hurting the wholesale business?
17:49 So there's no evidence that we can quantify, but unequivocally, I don't think we can argue that it isn't. So there are declines in wholesale. We see that more in the health food channel. So I commented in the press release as well as in the introduction to the call today that Specialty retail, just as a channel, and by specialty retail I mean kind of small box specialty retail, not large grocery stores or Walmart or anything like that, but the smaller mom-and-pop type stores are really challenged in the current environment. You all know we sell a lot through GNC, and in particular the GNC Franchise Network, and we kind of talked about the declines we're seeing there.
18:38 We're seeing similar declines in the HFS side of Erwin, but not so much in the mass market side. So are some of those people that are, you know, now that more of our products are available on Amazon and there's a lot more sales happening on Amazon, are some of those people migrating from the brick and mortar stores? Absolutely, right? I don't think we can argue at all that they're not. But how much of that, you know, what the impact is of that, we can't quantify, right? We don't know. who it was that was buying in the HFS channel, and we don't know who it is that's buying in the Amazon channel. But certainly some people are choosing to buy online.
19:18 All right. Thank you.
19:19 Yep. Thank you, Sean. Once again, if you have a question or a comment, please indicate so by pressing star 1 on your touchtone phone. The next question comes from Igor Novgorodsev with Lairs Capital. Please proceed.
19:37 Hello, Dayton, and it's nice to be, again, a shareholder of FitLife after a long track. So I have a few questions. Legacy GNC, specifically the stores, what's the situation there? Is it still representing a significant amount of your sales, and is the decline the result of diminishing store counts of GNC franchisees, or are they just buying less, or some combination of the two?
20:07 Yeah, so first of all, welcome back to being a shareholder. It is a combination of the two. So it's probably not my business to kind of give their numbers, but there's been a double-digit decline in the number of doors, and I'm talking here specifically franchise locations. So when the stores close, we lose all of those sales. Maybe some of it transfers to other stores that are close by. But then even in remaining stores, we are seeing, in our numbers, meaningful same-store declines. So you add those two up, it's a 20%-plus decline. In terms of the impact on the business overall, GNC at this point is probably close to, I'm going to guess, I don't have the numbers in front of me, but maybe about $10 million of our revenue, so maybe about a 10% customer.
21:02 There are some things we're doing to address that. We have a handful of brands that have historically been exclusive to GNC. They're going to largely remain exclusive to GNC, but in the face of declines, there's some things that we can do both internationally as well as maybe in independent or in geographic markets where there is no large presence of GNC franchisees. So we can start to take those brands to stores, locations that don't compete with GNC. So hopefully that kind of frames the current situation, but call it about $10 million of revenue on an LTM basis, and it's been declining, again, double digits. I don't have the exact number in front of me, but depending on the quarter, maybe 15% to 25%. Okay.
21:59 The other question I have is Amazon changed the algorithm, which I believe I discussed with you previously quite in detail. And I understand that you have a team behind your Amazon presence. How much progress have you made so far to address the issues of the changed algorithm, which wasn't favorable to you? And how much is left to do and kind of where you're at at this point?
22:26 Yeah, so Amazon is an always-changing black box is maybe one way to describe it. I think that we're seeing good momentum on most of the brands except the MRC brands. And again, I gave some numbers earlier in the call that perhaps shows a reduction in the decline of the MRC brands. I commented in the prepared remarks, not all of our brands are declining, and our online revenue is growing sequentially. I think Q3 was a very small downtick compared to Q2, but when you take into account, again, Prime Day shifting from Q3 into Q2, and you kind of normalize for that, even though MRC is declining, the other brands are growing enough to offset that, and then some.
23:19 So So we're seeing some progress. What I've commented before is we see a very strong correlation, very, very high correlation between the percent sales that a brand is getting on Amazon and its performance on Amazon. And that's somewhat counterintuitive. But the more beholden we are or the brand is to Amazon, the less off-Amazon presence it has, the worse it does. And that's kind of MRC. definitionally, right? Something like 99% of our revenue historically, again, came from Amazon. So are we selling more off Amazon? A bit. We've shifted quite a lot of the advertising dollars for the MRC brands off of Amazon and more kind of DTC, so think Google, Meta.
24:07 We've been doing a lot on TikTok. So we've shifted the advertising dollars to try and build awareness off Amazon and But, you know, looking at some of the other brands, you know, I commented MusclePharm is, you know, every month for the past couple few months has been a new all-time high for MusclePharm. So when the brand has had stronger off-Amazon presence and awareness, it is doing better on Amazon. So our Amazon declines are really an MRC issue. And then we have one other Brand. It's really not a brand. It's a product that had a really big run last year, and it's not doing as well this year. So it was a product that got really hot and now is falling somewhat out of favor, at least compared to last year.
24:56 So if I take those out, everything else is fine. So in terms of your specific question, how are we doing with the algorithm changes, I think we're doing pretty well with You know, Dr. Tobias and MRC in particular, the place where we're still seeing the biggest declines, but perhaps not as significant as they have been.
25:20 Okay. My other question, which you alluded to, is the ingredients and other costs basically going into your gross margin. Have these spiked mostly because of the situation with diesel and oil, or this is just an ongoing situation which is specific to other things? In other words, would you think that if the prices of oil come down for one reason or another, or diesel, your prices will significantly come down, or it's really ingredient by ingredient, and those are specific problems to your ingredients?
25:56 Yeah, so there's two ingredients that have been a challenge. And when I say been a challenge, I actually feel like we've been on top of it. And because of the purchases we've been making over the last, gosh, I think we started forward buying protein last year. We don't expect to see these in our cost of goods, right? Because we're expending the cash sooner to lock in the lower prices. I don't think it really has anything to do with the cost of oils. I would say the bigger issue with the cost of oil is gas prices being high is affecting the consumer along with a whole lot of other things affecting the consumer and that's affecting kind of where they spend their money and how they spend their money. The issues with these two ingredients, so whey protein is just, protein has become more and more popular, partially driven by the GLP-1 trends that have been going on and doctors tell people as they lose weight, as they take the GLP-1s, they need to supplement with protein. You see it anytime you walk into a convenience store or a grocery store, right? Proteins in everything now, from candy bars to it's in your Starbucks coffee, it's in your potato chips, right? People are putting protein in everything.
27:03 The net result of that is whey, which has been our primary protein that we have used, has gone from about $2.50 a pound a couple years ago to it peaked around $15 a pound. It's now back down to between $9 and $10. What we did is we started forward buying the way last year. We bought a bunch at about $5 a pound, and we bought a bunch at $7.17 a pound. We're about to finish using that up. Because of that, our margins have not been affected perhaps maybe as much as other people's have. The other thing is we have not had to be as aggressive in raising our prices. We have raised price, but certainly not as much as a lot of other people.
27:50 And that, I think, is one big reason why the MusclePharm brand is doing well right now. I think we're stealing share because we have a bit of a cost advantage because we locked in the pricing. So we're about to finish production with the last of our way that we bought at $7.17. If we were to buy right now in the spot market, it's between $9 and $10. So, you know, we'll probably, once we start dipping into the $9 and $10 way or buying on the spot market, you know, our costs will go up a bit and we'll probably raise price again. The other big area, though, and this is a new one, is fish oil. And I'm not a fisherman. I can't explain all of the details, but there are fishing seasons when, and this is a global phenomenon. This has nothing to do with the U.S.
28:36 In fact, most of the fish oil that is consumed in the U.S. comes from outside the U.S. There's Fishing seasons down around South America, Peru in particular, and when the catch is not strong or the fish are too small, they have to throw them back, and Peru actually, I think, canceled the last fishing season. What I would encourage you all to do is just go to Google, go to AI, and just ask what's going on with the fish oil market, and it'll explain it to you better than I can. To kind of give very specific numbers, in the third quarter, we paid $1.4 million in was the final payment we made for the protein that we had locked in. And again, that will be consumed over the next couple months, probably, or sold in the next couple few months and converted to cash.
29:21 On the fish oil side, most of that is still in prepaids, but we made a payment, a few hundred thousand, I can't remember the exact number, in Q3, and then another payment very early in Q4. and both of those payments combined, again, I'm going to guess it's $600,000 to $800,000. With that, we've kind of locked in our cost on fish oil for, we think, probably until Q4 of 27. So it's a cash outflow now, but when it flows to the P&L over the next year, right, it'll be at favorable cost. We hope to be able to perhaps gain some share on the fish oil side as well, like we're seeing in MusclePharm. Long answer, but hopefully that addressed your question.
30:10 Okay. No, no, no. This is more detailed. Thank you, and I'll just take privilege to ask the last question. So you alluded that certain categories are doing better and certain categories are doing worse, and it has to do basically with consumer being squeezed by higher prices. So which categories are doing better? Which ones are doing worse?
30:34 Yeah, I think the way I would say it is everything is doing worse than it was a year ago, is probably the way I would say it. So like, you know, again, MusclePharm is doing great right now, but the consumer headwinds that, look, we've been pretty open, and when we see something, we talk about it. I think it was the third quarter call last year when we first started talking about seeing these kind of consumer headwinds, and you kind of see it in the numbers. So You know, where our biggest challenges are, like if I, there's two areas, two problems, right? And we've talked about this, I think, somewhat extensively. Number one is MRC on Amazon. And number two is specialty retail channel, right? And so that includes GNC and that includes health food stores for the Irwin brands. If you ignore those and, you know, we can't completely ignore them and pretend they're not there.
31:31 But if you isolate those from the rest of the business, I don't really see anything in the rest of the business where I am concerned. It's generally flat, maybe down a little bit or up a little bit or growing. In fact, I commented in our remarks, if you take the last four quarters, the business is relatively stable. Revenue has been within about a million dollars or a little bit more than a million dollars in each quarter over the last four quarters. EBITDA has been within a couple hundred, between 3.3 and 3.7. So these challenges, whether it's GNC or the health food stores for Erwin or MRC, are being offset by strength in other areas. So I just want to make it clear to people, this is not the sky is falling and everything is going down. We're dealing with MRC issues and we're dealing with specialty retail issues, that channel, which, by the way, I don't think is specific to our brands.
32:29 It's not like our brands are down at GNC and everyone else is killing it. Or our brands are struggling in HFS and everyone else is killing it, particularly in the smaller independent HFS stores. So hopefully that answers your question. But GNC, specialty retail are our problem areas. Everything else, I'm not losing any sleep over.
32:51 Okay. Thank you so much.
32:52 Yep. No problem.
32:53 Take care. We have a follow-up question coming from Sean Gallen with Roth Capital. Please proceed.
33:02 Thanks again. You addressed a couple of the other follow-ups I had, but I do have a couple left. Can you be more specific about how the margins at MusclePharm are trending? I think that going back a year or so ago, that was an issue and it sounds like things are going better on the revenue side. Can you talk a little bit more about the margins there?
33:22 Sure. So, and, you know, back when we used to break out the numbers for MusclePharm, you know, we used to generate, call it 30% margins. And then we, you know, when we bought, shortly after we bought the brand and we had, you know, built some inventory, we wanted to grow the brand. And so we said, hey, we're going to be promotional. We're going to, you know, try and build distribution, et cetera, et cetera. And margins went from like 30%. Down to like 20%. And then I think one quarter, maybe even two quarters, a little bit below 20%. Then we had the spike in protein prices. And we basically told, there's a number of protein companies that sell protein internationally that are very price aggressive and really just, you know, I'd call them bottom feeders, but that maybe makes it sound bad, right?
34:13 It's just, it's just their business model. When prices of protein went up, we're just like, sorry, we're not going to sell to you guys anymore, right? Or certainly not at those prices. So part of what we've seen is a shift away from the low margin international business. And look, we have raised prices wholesale to everyone. So some of those people may continue to buy, but certainly not in the volumes that they used to buy before. So margins are several hundred basis points higher than they were when we last broke them out, which was when they were around, call it 20-ish percent. So we're not up to 30% yet, but we're north of 25%. I'll just kind of maybe leave it at that. And again, I think we're helped by the fact that we've locked in our protein prices.
35:00 We have raised our price both at wholesale and at retail, but not to the extent that other people have. So I think we've benefited from our forward purchasing there.
35:13 And then finally, and this is more generally speaking, you know, we're now slightly more than halfway through the fourth quarter. You commented a little bit on some things continuing, but more generally, you know, do you think that all the trends that you've seen in the third quarter have continued into the fourth?
35:32 Yeah, so online continues to be very strong. MusclePharm, you know, October revenue I think is probably quite a bit higher. I'll look it up here online while we're talking quite a bit higher than it was, I believe, in September. Yeah, I would say generally the trends have continued. Revenue, if I look at shipments, revenue for October is roughly similar to what we've seen throughout the year. We see fluctuations primarily on the wholesale side. We had a lot of product that was in transit at the end of October that will show up in November revenue, but the basic trends are the same. So nothing new to report in that regard.
36:18 But here I'll tell you some MusclePharm online, at least directionally. Yeah, I mean, like October revenue was probably several percent, you know, let's see. Yeah, call it October revenue for MusclePharm online was 10% higher than September revenue. Now we also had fall prime days, or they don't call it prime day, but they're October. Prime, essentially for Amazon. It happens in October. So October is generally a strong month for online across all of the brands, not just MusclePharm.
36:53 Okay. And the MRC is still trending as it was?
36:57 Yeah. MRC, nothing different than the kind of previous trends that I called out. I will say again, I don't know. I don't have a number for Q4. I'm not giving guidance. I just remind everyone Q4 is generally the weakest quarter. Just seasonally in the supplement business, and then Q1 and Q2 are generally stronger. We didn't, unfortunately, experience that earlier this year, the Q1, Q2 part, but we're hoping that that pattern resumes starting next year.
37:30 Thank you very much, James.
37:32 Yep. Thank you, Sean. Okay. We currently have no further questions in the queue. This concludes the Q&A portion of the call. I'd like to turn the floor back to management for any closing remarks.
37:44 Thank you all for participating in the call. If you have any other questions, either now or in the coming months, please feel free to reach out, and we will look forward to talking to you on our next call. Thank you. This concludes today's conference, and you may disconnect your lines at this time. Thank you for your participation.
Follow FitLife Brands, Inc. into a list and get an email when it puts out news.
CEO
Lairs Capital
Lake Street
Roth Capital